Acadia Pharmaceuticals | Vertriebs- Und Verwaltungskosten



Selling And Administration Expenses Veränderung Datum
Acadia Pharmaceuticals USD 123.66M 2.71M 2025-06
ALKERMES USD 153.87M 17.83M 2025-06
Alnylam Pharmaceuticals USD 323.31M 83.36M 2025-06
Biogen USD 583.8M 11.3M 2025-06
BioMarin Pharmaceutical USD 232.28M 26.16M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Corcept Therapeutics USD 103.85M 13.19M 2025-06
Cytokinetics USD 65.72M 8.35M 2025-06
Eisai JPY 100.16B 6.34B 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Incyte USD 331.02M 5.33M 2025-06
J&J USD 5.89B 777M 2025-06
Moderna USD 230M 18M 2025-06
Neurocrine Biosciences USD 286.3M 9.8M 2025-06
Pfizer USD 3.42B 406M 2025-06
Prothena USD 15.91M 938K 2025-06
PTC Therapeutics USD 85.26M 76.66M 2025-06
Sarepta Therapeutics USD 69.89M 63.74M 2025-06
Ultragenyx Pharmaceutical USD 86.65M 1.15M 2025-06
Vertex Pharmaceuticals USD 424.6M 28.2M 2025-06


Acadia Pharmaceuticals Vertriebs- Und Verwaltungskosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.